Laleh Rashidian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Laleh Rashidian has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Anum Ali
Leslie Dan Faculty of Pharmacy University of Toronto Toronto Ontario Canada
3 shared publications- Sara J. T. Guilcher
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada
3 shared publications - Arrani Senthinathan
Leslie Dan Faculty of Pharmacy University of Toronto Toronto Ontario Canada
2 shared publications - Chantal Backman
School of Nursing, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada
2 shared publications Kerry Kuluski
2 shared publicationsWalter P. Wodchis
2 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Wiley in Journal of the American Geriatrics Society
Trends in Dispensing of Opioids and Benzodiazepines Among Older Adults Admitted for an Acute Hip Fracture Between 2008 and 2024 in Ontario, Canada
Introduction: Opioids and benzodiazepines (BZDs) are commonly prescribed for managing pain, anxiety, and sleep‐related problems following a hip fracture. Both opioids and BZDs carry risks of persistent dependence, falls, and mortality with long‐term use. Despite these risks, Canada lacks standardized prescribing guidelines for older adults with hip fracture. We examined population‐level trends in opioids and BZDs dispensing before hospitalization and up to 1‐year post‐discharge among older adults admitted for hip fractures in Ontario, Canada. Methods: We conducted a retrospective cohort study using linked health administrative data from ICES, Ontario, Canada. The cohort included individuals aged 66 years and older, residing in Ontario, admitted for an acute hip fracture between April 1, 2008, and March 31, 2024, and who survived for at least 275 days in the following year. Our primary outcome was post‐discharge opioids and BZDs dispensed, defined as ≥ 1 prescription dispensed within 1–365 days following discharge. Secondary outcomes included pre‐hospitalization dispensing, concurrent dispensing, and morphine equivalent dose. Results: A total of 114,055 eligible older adults were admitted with hip fractures between 2008 and 2024. Overall, BZDs dispensing declined from 33.7% in 2008 to 13.3% in 2024, while opioids dispensing peaked in 2015 at 55.8% and decreased to 44.6% in 2024. Hydromorphone and combination drug therapy were the most frequently dispensed opioid drug classes during pre‐hospitalization and post‐discharge periods following a hip fracture. Concurrent opioids and BZDs dispensed following a hip fracture decreased from 3.7% in 2008 to 1% in 2024. Among individuals with 90 days of continuous opioid dispensed, most received < 50 mg average daily morphine equivalents. Conclusion: We observed a substantial reduction in BZDs dispensing. However, opioids dispensing remained consistently high. These findings underscore the need for future research on initiatives to reduce opioids use in post‐fracture care, while recognizing that opioids remain an effective pain control drug.
- 9 October 2026
- Published by Wiley in Journal of the American Geriatrics Society
Open AccessTrends in Dispensing of Opioids and Benzodiazepines Among Older Adults Admitted for an Acute Hip Fracture Between 2008 and 2024 in Ontario, Canada
Introduction: Opioids and benzodiazepines (BZDs) are commonly prescribed for managing pain, anxiety, and sleep‐related problems following a hip fracture. Both opioids and BZDs carry risks of persistent dependence, falls, and mortality with long‐term use. Despite these risks, Canada lacks standardized prescribing guidelines for older adults with hip fracture. We examined population‐level trends in opioids and BZDs dispensing before hospitalization and up to 1‐year post‐discharge among older adults admitted for hip fractures in Ontario, Canada. Methods: We conducted a retrospective cohort study using linked health administrative data from ICES, Ontario, Canada. The cohort included individuals aged 66 years and older, residing in Ontario, admitted for an acute hip fracture between April 1, 2008, and March 31, 2024, and who survived for at least 275 days in the following year. Our primary outcome was post‐discharge opioids and BZDs dispensed, defined as ≥ 1 prescription dispensed within 1–365 days following discharge. Secondary outcomes included pre‐hospitalization dispensing, concurrent dispensing, and morphine equivalent dose. Results: A total of 114,055 eligible older adults were admitted with hip fractures between 2008 and 2024. Overall, BZDs dispensing declined from 33.7% in 2008 to 13.3% in 2024, while opioids dispensing peaked in 2015 at 55.8% and decreased to 44.6% in 2024. Hydromorphone and combination drug therapy were the most frequently dispensed opioid drug classes during pre‐hospitalization and post‐discharge periods following a hip fracture. Concurrent opioids and BZDs dispensed following a hip fracture decreased from 3.7% in 2008 to 1% in 2024. Among individuals with 90 days of continuous opioid dispensed, most received < 50 mg average daily morphine equivalents. Conclusion: We observed a substantial reduction in BZDs dispensing. However, opioids dispensing remained consistently high. These findings underscore the need for future research on initiatives to reduce opioids use in post‐fracture care, while recognizing that opioids remain an effective pain control drug.
- Open Access
- 23 April 2026
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (6) , 1658-1667
The Association Between Hospital Harms and 1‐Year Mortality Following a Hip Fracture in Ontario, Canada: A Cohort Study
Background: Hip fractures are a significant public health concern, associated with substantial morbidity and mortality. Mortality is the most serious consequence of hip fractures, with a 1‐year rate ranging from 14% to 36%. Hospital harms are also more prevalent among older adults with hip fractures, further increasing their risk of mortality. This study aimed to assess the incremental risk of all‐cause mortality up to one‐year post‐discharge among hip fracture patients who experienced hospital harm. Methods: A population‐based retrospective cohort study using linked health administrative data in Ontario, Canada, was conducted. The cohort included individuals aged 50 years and older hospitalized for hip fractures between April 2008 and March 2022 and discharged alive. All‐cause mortality within one‐year post‐discharge was the primary outcome, and hospital harm was the main exposure. We used Cox proportional hazards models to assess the association between hospital harm and mortality, adjusting for covariates (e.g., age, sex, comorbidities, frailty, and surgery status). Results: A total of 131,472 patients admitted for acute hip fractures and discharged alive were included in the study, with a mean age of 80.67 ± 10.56 years. Of these patients, 17.5% experienced hospital harm during their admission for an acute hip fracture. The overall mortality rate was 18.4% within 1‐year post‐discharge. After adjusting for covariates, patients who experienced overall harm had a 42% higher risk of all‐cause mortality during the 1‐year period post‐discharge (adjusted hazard ratio, aHR = 1.42, 95% confidence interval, CI: 1.38–1.46) compared to those without harm. Conclusion: Experiencing hospital harm significantly increased the risk of 1‐year mortality after discharge among hip fracture patients. These findings underscore the importance of improving patient safety and minimizing preventable harm in hospital settings. Mitigation strategies, such as enhanced monitoring and safety protocols, could reduce hospital harm and improve long‐term survival. Future research should focus on evaluating such interventions.
- 23 April 2026
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (6) , 1658-1667
Open AccessThe Association Between Hospital Harms and 1‐Year Mortality Following a Hip Fracture in Ontario, Canada: A Cohort Study
Background: Hip fractures are a significant public health concern, associated with substantial morbidity and mortality. Mortality is the most serious consequence of hip fractures, with a 1‐year rate ranging from 14% to 36%. Hospital harms are also more prevalent among older adults with hip fractures, further increasing their risk of mortality. This study aimed to assess the incremental risk of all‐cause mortality up to one‐year post‐discharge among hip fracture patients who experienced hospital harm. Methods: A population‐based retrospective cohort study using linked health administrative data in Ontario, Canada, was conducted. The cohort included individuals aged 50 years and older hospitalized for hip fractures between April 2008 and March 2022 and discharged alive. All‐cause mortality within one‐year post‐discharge was the primary outcome, and hospital harm was the main exposure. We used Cox proportional hazards models to assess the association between hospital harm and mortality, adjusting for covariates (e.g., age, sex, comorbidities, frailty, and surgery status). Results: A total of 131,472 patients admitted for acute hip fractures and discharged alive were included in the study, with a mean age of 80.67 ± 10.56 years. Of these patients, 17.5% experienced hospital harm during their admission for an acute hip fracture. The overall mortality rate was 18.4% within 1‐year post‐discharge. After adjusting for covariates, patients who experienced overall harm had a 42% higher risk of all‐cause mortality during the 1‐year period post‐discharge (adjusted hazard ratio, aHR = 1.42, 95% confidence interval, CI: 1.38–1.46) compared to those without harm. Conclusion: Experiencing hospital harm significantly increased the risk of 1‐year mortality after discharge among hip fracture patients. These findings underscore the importance of improving patient safety and minimizing preventable harm in hospital settings. Mitigation strategies, such as enhanced monitoring and safety protocols, could reduce hospital harm and improve long‐term survival. Future research should focus on evaluating such interventions.
- Open Access
- 4 November 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (11) , e0005333
Leveraging public engagement to improve healthcare quality: The role of community and stakeholder engagement in Colombia’s National Quality of Care Strategy
Public engagement, also referred to as community and stakeholder engagement (CSE), and high-quality care are core components of strategies to achieve universal health coverage (UHC), one of the United Nations Sustainable Development Goals. As part of the movement toward achieving UHC, Colombia has developed one of the first national quality of care strategies in the Latin America and Caribbean region. However, the degree to which public engagement was considered in the development and implementation of Colombia’s National Quality of Care Strategy (the Strategy) is not clearly understood. With a growing global consensus on the importance of public engagement in health systems and policy, we use a qualitative case study comprising a document analysis followed by qualitative interviews, to explore how CSE has been considered in the design and implementation of the Strategy. In an analysis guided by the Lavery framework for CSE, we address the following three research objectives: 1) describe how community and stakeholder engagement is reflected in the Strategy; 2) explore approaches undertaken to engage community and stakeholders in the development and implementation of the Strategy and their perceived effectiveness; and 3) report on strengths and opportunities for improving CSE in health policymaking in Colombia. Our findings demonstrate a strong written commitment to CSE. However, the implementation of engagement strategies fell short in including community (i.e., patients and citizens), particularly those from structurally marginalized communities, due in part to inconsistent political and financial support and the absence of evaluation mechanisms. These findings have important implications for Colombia and other comparable jurisdictions aiming to enhance public engagement in health policy making. Our study highlights the need to move beyond symbolic participation toward inclusive, well-resourced, and systematically evaluated engagement strategies.
- 4 November 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (11) , e0005333
Open AccessLeveraging public engagement to improve healthcare quality: The role of community and stakeholder engagement in Colombia’s National Quality of Care Strategy
Public engagement, also referred to as community and stakeholder engagement (CSE), and high-quality care are core components of strategies to achieve universal health coverage (UHC), one of the United Nations Sustainable Development Goals. As part of the movement toward achieving UHC, Colombia has developed one of the first national quality of care strategies in the Latin America and Caribbean region. However, the degree to which public engagement was considered in the development and implementation of Colombia’s National Quality of Care Strategy (the Strategy) is not clearly understood. With a growing global consensus on the importance of public engagement in health systems and policy, we use a qualitative case study comprising a document analysis followed by qualitative interviews, to explore how CSE has been considered in the design and implementation of the Strategy. In an analysis guided by the Lavery framework for CSE, we address the following three research objectives: 1) describe how community and stakeholder engagement is reflected in the Strategy; 2) explore approaches undertaken to engage community and stakeholders in the development and implementation of the Strategy and their perceived effectiveness; and 3) report on strengths and opportunities for improving CSE in health policymaking in Colombia. Our findings demonstrate a strong written commitment to CSE. However, the implementation of engagement strategies fell short in including community (i.e., patients and citizens), particularly those from structurally marginalized communities, due in part to inconsistent political and financial support and the absence of evaluation mechanisms. These findings have important implications for Colombia and other comparable jurisdictions aiming to enhance public engagement in health policy making. Our study highlights the need to move beyond symbolic participation toward inclusive, well-resourced, and systematically evaluated engagement strategies.